BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
8 results:

  • 1. ALK Translocation in ALK-Positive Mesenchymal tumors: Diagnostic and Therapeutic Insights.
    Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
    Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
    Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
    Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.
    Nada A; Jetton JG
    Pediatr Nephrol; 2021 Aug; 36(8):2227-2255. PubMed ID: 33245421
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
    Moskop A; Pommert L; Thakrar P; Talano J; Phelan R
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28739. PubMed ID: 33009894
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Geriatric specificities of localized renal cell carcinoma].
    Mongiat-Artus P; Paillaud E; Caillet P; Albrand G; Neuzillet Y
    Prog Urol; 2019 Nov; 29(14):865-873. PubMed ID: 31771769
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
    Zhou W; Zhang GL
    PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell carcinoma: Data From a Multicenter Cohort in Japan.
    Komura K; Hashimoto T; Tsujino T; Muraoka R; Tsutsumi T; Satake N; Matsunaga T; Yoshikawa Y; Takai T; Minami K; Taniguchi K; Uehara H; Tanaka T; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
    Ann Surg Oncol; 2019 Sep; 26(9):2994-3004. PubMed ID: 31240592
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Intraocular manifestations of systemic neoplasms].
    Bechrakis NE; Haas G; Blatsios G
    Klin Monbl Augenheilkd; 2011 Jul; 228(7):586-92. PubMed ID: 21739400
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.